Description
Description
This page contains brief details about the drug peg l-asparaginase, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects
Date of Approval
Peg-L-Asparaginase is a class of antitumor drug that belongs to the category of medicines known as enzymes known as hydrolases. It was approved on 30 June 2021 to treat Acute Lymphoblastic Leukaemia.
Mechanism of Action of Peg L-Asparaginase
Cancer cells need a substance called asparagine to survive. This Injection works by lowering the levels of asparagine in the body.
Uses of Peg L-Asparaginase
Peg-L-Asparaginase is used to treat Acute Lymphoblastic Leukaemia (a type of cancer of the white blood cells).
Peg L-Asparaginase Dosage available
It will be given to you by your health care professional. Do not self-administer. Your physician will decide the dose and duration of your treatment based on the disease severity and other factors.
